Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 58 results.
User Information
Export Records
  1. 1.   The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1
  2. Sanchez-Solana, Beatriz; Wang, Dunrui; Qian, Xiaolan; Velayoudame, Parthibane; Simanshu,Dhirendra; Acharya,Jairaj; Lowy, Douglas R
  3. Molecular Cancer. 2021, Nov 02; 20(1):
  1. 2.   Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
  2. Mehalko,Jennifer; Drew, Matthew; Snead,Kelly; Denson,John-Paul; Wall,Vanessa; Taylor,Troy; Sadtler, Kaitlyn; Messing,Simon; Gillette, William; Esposito,Dom
  3. Protein expression and purification. 2021, Mar; 179: 105802.
  1. 3.   Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
  2. Zhou, Tongqing; Tsybovsky,Yaroslav; Gorman, Jason; Rapp, Micah; Cerutti, Gabriele; Chuang, Gwo-Yu; Katsamba, Phinikoula S; Sampson, Jared M; Schön, Arne; Bimela, Jude; Boyington, Jeffrey C; Nazzari, Alexandra; Olia, Adam S; Shi, Wei; Sastry, Mallika; Stephens,Tyler; Stuckey, Jonathan; Teng, I-Ting; Wang, Pengfei; Wang, Shuishu; Zhang, Baoshan; Friesner, Richard A; Ho, David D; Mascola, John R; Shapiro, Lawrence; Kwong, Peter D
  3. Cell Host & Microbe. 2020, Dec 9; 28: 867-+.
  1. 4.   Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
  2. Mehalko,Jennifer; Drew, Matthew; Snead,Kelly; Denson,John-Paul; Wall,Vanessa; Taylor,Troy; Sadtler, Kaitlyn; Messing,Simon; Gillette, William; Esposito,Dom
  3. Protein expression and purification. 2020, Nov 25; 105802.
  1. 5.   A short review on antibody therapy for COVID-19
  2. Kumar, G. Venkat; Ramakrishnan, S.; Ramakrishnan,Saminathan
  3. New microbes and new infections. 2020, MAY; 35
  1. 6.   Protein Engineering in the Ubiquitin System: Tools for Discovery and Beyond
  2. Zhao, Bo; Tsai,Yien Che; Jin, Bo; Wang, Bufan; Wang, Yiyang; Zhou, Han; Carpenter, Tomaya; Weissman,Allan; Yin, Jun
  3. Pharmacological reviews. 2020, Apr; 72(2): 380-413.
  1. 7.   Unique repression domains of Pumilio utilize deadenylation and decapping factors to accelerate destruction of target mRNAs
  2. Arvola, Rene M.; Chang, Chung-Te; Buytendorp, Joseph P.; Levdansky,Yevgen; Valkov,Eugene; Freddolino, Peter L.; Goldstrohm, Aaron C.
  3. NUCLEIC ACIDS RESEARCH. 2020, Feb 28; 48: 1843-1871.
  1. 8.   Generation and characterization of monoclonal antibodies that recognize human and murine supervillin protein isoforms
  2. Smith, Tara C.; Saul, Rick; Barton, Elisabeth R.; Luna, Elizabeth J.
  3. PloS one. 2018, Oct 17; 13(10):
  1. 9.   Cell-free formation and interactome analysis of caveolae
  2. Jung, Wooram; Sierecki, Emma; Bastiani, Michele; O'Carroll, Ailis; Alexandrov, Kirill; Rae, James; Johnston, Wayne; Hunter, Dominic J. B.; Ferguson, Charles; Gambin, Yann; Ariotti, Nicholas; Parton, Robert G.
  3. Journal of Cell Biology. 2018, Jun 04; 217(6): 2141-2165.
  1. 10.   Multiple-Targeting and Conformational Selection in the Estrogen Receptor: Computation and Experiment
  2. Yuan, P.; Liang, K. W.; Ma, B. Y.; Zheng, N.; Nussinov, R.; Huang, J.
  3. Chemical Biology & Drug Design. 2011, Jul; 78(1): 137-149.
  1. 11.   Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor
  2. Xiao, X. D.; Feng, Y.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Biochemical and Biophysical Research Communications. 2011, Jul; 411(2): 253-258.
  1. 13.   Molecular Aspects of HTLV-1 Entry: Functional Domains of the HTLV-1 Surface Subunit (SU) and Their Relationships to the Entry Receptors
  2. Jones, K. S.; Lambert, S.; Bouttier, M.; Benit, L.; Ruscetti, F. W.; Hermine, O.; Pique, C.
  3. Viruses-Basel. 2011, Jun; 3(6): 794-810.
  1. 14.   Interaction between the HTLV-I envelope and cellular proteins: impact on virus infection and restriction
  2. Ilinskaya, A.; Heidecker, G.; Jones, K.
  3. Future Medicinal Chemistry. 2010, Nov; 2(11): 1651-1668.
  1. 15.   Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome
  2. Jang, H.; Arce, F. T.; Ramachandran, S.; Capone, R.; Azimova, R.; Kagan, B. L.; Nussinov, R.; Lal, R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Apr; 107(14): 6538-6543.
  1. 16.   Preferred drifting along the DNA major groove and cooperative anchoring of the p53 core domain: mechanisms and scenarios
  2. Pan, Y. P.; Nussinov, R.
  3. Journal of Molecular Recognition. 2010, Mar-Apr; 23(2): 232-240.
  1. 17.   The Hypervariable Region of K-Ras4B Is Responsible for Its Specific Interactions with Calmodulin
  2. Abraham, S. J.; Nolet, R. P.; Calvert, R. J.; Anderson, L. M.; Gaponenko, V.
  3. Biochemistry. 2009 48(32): 7575-7583.
  1. 18.   Functional Analysis of N-Terminal Residues of Ty1 Integrase
  2. Moore, S. P.; Garfinkel, D. J.
  3. Journal of Virology. 2009 83(18): 9502-9511.
  1. 19.   Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
  2. Norris, J. D.; Joseph, J. D.; Sherk, A. B.; Juzumiene, D.; Turnbull, P. S.; Rafferty, S. W.; Cui, H. X.; Anderson, E.; Fan, D. J.; Dye, D. A.; Deng, X.; Kazmin, D.; Chang, C. Y.; Willson, T. M.; McDonnell, D. P.
  3. Chemistry & Biology. 2009 16(4): 452-460.
  1. 20.   The mechanism of RNase III action: How Dicer dices
  2. Ji, X. H.
  3. Rna Interference. 2008 320: 99-116.
  1. 21.   Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env
  2. Li, K. J.; Zhang, S. J.; Kronqvist, M.; Wallin, M.; Ekstrom, M.; Derse, D.; Garoff, H.
  3. Journal of Virology. 2008 82(14): 7135-7143.
  1. 22.   P53-induced DNA bending: The interplay between p53-ONA and p53-p53 interactions
  2. Pan, Y. P.; Nussinov, R.
  3. Journal of Physical Chemistry B. 2008 112(21): 6716-6724.
  1. 23.   Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
  2. Zhu, Z. Y.; Chakraborti, S.; He, Y.; Roberts, A.; Sheahan, T.; Xiao, X. D.; Hensley, L. E.; Prabakaran, P.; Rockx, B.; Sidorov, I. A.; Corti, D.; Vogel, L.; Feng, Y.; Kim, J. O.; Wang, L. F.; Baric, R.; Lanzavecchia, A.; Curtis, K. M.; Nabel, G. J.; Subbarao, K.; Jiang, S.; Dimitrov, D. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Jul; 104(29): 12123-12128.
  1. 24.   Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins
  2. Baleja, J. D.; Cherry, J. J.; Liu, Z. G.; Gao, H.; Nicklaus, M. C.; Voigt, J. H.; Chen, J. J.; Androphy, E. J.
  3. Antiviral Research. 2006, Oct; 72(1): 49-59.
  1. 25.   Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells
  2. Jones, K. S.; Fugo, K.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Lisinski, I.; Cushman, S. W.; Jacobson, S.; Ruscetti, F. W.
  3. Journal of Virology. 2006, Sep; 80(17): 8291-8302.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel